Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses"

Stroke. 2014 Dec;45(12):e303. doi: 10.1161/STROKEAHA.114.007340. Epub 2014 Oct 23.

Authors

A-Ching Chao¹, Helen L Po², Lung Chan³

Affiliations

¹ Department of Neurology, Kaohsiung Medical University Hospital, and Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
² Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan.
³ Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan.

PMID: 25342029
DOI: 10.1161/STROKEAHA.114.007340

No abstract available

Publication types

Letter
Comment

MeSH terms

Brain Ischemia / drug therapy*
Female
Fibrinolytic Agents / therapeutic use*
Humans
Male
Stroke / drug therapy*
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator